suggested three novel potential biomarkers for early detection of DN in T2DM patients’ serum: neutrophil gelatinase-associated lipocalin (NGAL), beta-trace protein (beta TP), and microRNA-130b (miR-130b) (5). This evidence concerns the gene LCN2 and type 2 diabetes mellitus.